Q1 2023 Financial Performance

10 IRX is our Competitive Differentiator Q1 2023 Highlights¹ Orders/Revenue Adj. EBITDA² Adj. EPS² Continued momentum Organic orders: Up 8% YoY Organic revenue2: Up 20% YoY Q1'23 ending backlog up -15% YoY and -10% QoQ Book to Bill of 1.09x $400M with margin of 24.6% Up $97M YOY, an increase of 32% 190 bps improvement YoY Adjusted EPS of $0.65 +33% vs prior year YoY growth includes ($0.05) in interest expense headwinds $148M Operating Cash Flow: $170M Capex: ($22M) $2.2B 1.1x $1.1B cash on hand at end of Q1; down $0.5B vs prior quarter, primarily driven by SPX Flow Air Treatment acquisition Amended, extended and upsized revolving credit facility to $2B, increasing liquidity by $0.9B Improved 0.1x vs prior year Increased 0.3x vs prior quarter; largely due to timing of SPX Flow Air Treatment acquisition Free Cash Flow2 • Liquidity Net Leverage² 1 All figures as shown and associated comparisons based on continuing operations. 2 Non-GAAP measure (definitions and/or reconciliations in appendix). VALUES We foster inspired teams Deploy Talent INGERSOLL RAND IRX EXECUTION EXCELLENCE EXECUTION We are committed to making our customers successful Expand Margins Allocate Capital Effectively STRATEGIC FOCUS moving forward with humility & integrity We are bold in our aspirations while Accelerate Growth Lead Sustainably We think and act like owners (IR) Ingersoll Rand

View entire presentation